BRIEF-Sarepta Therapeutics Reiterates 2025 Rev Guidance Of $2.9 Bln-$3.1 Bln

Reuters
14 Jan
BRIEF-<a href="https://laohu8.com/S/SRPT">Sarepta Therapeutics</a> Reiterates 2025 Rev Guidance Of $2.9 Bln-$3.1 Bln

Jan 13 (Reuters) - Sarepta Therapeutics Inc SRPT.O:

  • SAREPTA THERAPEUTICS REPORTS PRELIMINARY* FOURTH QUARTER AND FULL-YEAR 2024 NET PRODUCT REVENUE

  • SAREPTA THERAPEUTICS INC - REITERATES 2025 REVENUE GUIDANCE OF $2.9-$3.1 BILLION

Source text: ID:nBw4hkglxa

Further company coverage: SRPT.O

(((( Reuters.Briefs@thomsonreuters.com ;));))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10